title: Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies.
abstract: α-dystroglycan (α-DG) is a peripheral membrane protein that is an integral component of the dystrophin-glycoprotein complex. In an inherited subset of muscular dystrophies known as dystroglycanopathies, α-DG has reduced glycosylation which results in lower affinity binding to several extracellular matrix proteins including laminins. The glycosylation status of α-DG is normally assessed by the binding of the α-DG antibody IIH6 to a specific glycan epitope on α-DG involved in laminin binding. Immunocytochemistry and immunoblotting are two of the most widely used methods to detect the amount of α-DG glycosylation in muscle. While the interpretation of the presence or absence of the epitope on muscle using these techniques is straightforward, the assessment of a mild defect can be challenging. In this study, flow cytometry was used to compare the amount of IIH6-reactive glycans in fibroblasts from dystroglycanopathy patients with defects in genes known to cause α-DG hypoglycosylation to the amount in fibroblasts from healthy and pathological control subjects. A total of twenty one dystroglycanopathy patient fibroblasts were assessed, as well as fibroblasts from three healthy controls and seven pathological controls. Control fibroblasts have clearly detectable amounts of IIH6-reactive glycans, and there is a significant difference in the amount of this glycosylation, as measured by the mean fluorescence intensity of an antibody recognising the epitope and the percentage of cells positive for the epitope, between these controls and dystroglycanopathy patient fibroblasts (p<0.0001 for both). Our results indicate that the amount of α-DG glycosylation in patient fibroblasts is comparable to that in patient skeletal muscle. This method could complement existing immunohistochemical assays in skeletal muscle as it is quantitative and simple to perform, and could be used when a muscle biopsy is not available. This test could also be used to assess the pathogenicity of variants of unknown significance in genes involved in dystroglycanopathies.
authors.affiliation: Dubowitz Neuromuscular Centre, UCL Institute of Child Health/Great Ormond Street Hospital for Children, London, United Kingdom.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Stevens
authors.forename: Silvia
authors.initials: S
authors.lastname: Torelli
authors.forename: Lucy
authors.initials: L
authors.lastname: Feng
authors.forename: Rahul
authors.initials: R
authors.lastname: Phadke
authors.forename: Maggie C
authors.initials: MC
authors.lastname: Walter
authors.forename: Peter
authors.initials: P
authors.lastname: Schneiderat
authors.forename: Ayad
authors.initials: A
authors.lastname: Eddaoudi
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Sewry
authors.forename: Francesco
authors.initials: F
authors.lastname: Muntoni
mesh_terms: D002648:Child; D049030:Dystroglycans / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D005434:Flow Cytometry; D006031:Glycosylation; D006801:Humans; D009136:Muscular Dystrophies / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology*
chemical_list: D049030:Dystroglycans
references.citation: Cytometry A. 2010 Sep;77(9):873-80
references.pmid: 20629196
references.citation: Hum Mol Genet. 2004 Apr 1;13(7):693-702
references.pmid: 14962982
references.citation: Muscle Nerve. 2002 Nov;26(5):644-53
references.pmid: 12402286
references.citation: Mol Biol Cell. 2007 Nov;18(11):4493-507
references.pmid: 17761532
references.citation: Am J Hum Genet. 2012 Dec 7;91(6):1135-43
references.pmid: 23217329
references.citation: Science. 2013 Apr 26;340(6131):479-83
references.pmid: 23519211
references.citation: J Mol Biol. 1999 Mar 26;287(2):253-64
references.pmid: 10080889
references.citation: Neuron. 2012 Dec 6;76(5):931-44
references.pmid: 23217742
references.citation: Hum Mol Genet. 2001 Dec 1;10(25):2851-9
references.pmid: 11741828
references.citation: Nature. 1992 Feb 20;355(6362):696-702
references.pmid: 1741056
references.citation: Hum Mutat. 2007 Oct;28(10):1020-7
references.pmid: 17559086
references.citation: N Engl J Med. 2011 Mar 10;364(10):939-46
references.pmid: 21388311
references.citation: J Med Genet. 2005 Dec;42(12):907-12
references.pmid: 15894594
references.citation: PLoS Genet. 2011 Dec;7(12):e1002427
references.pmid: 22242004
references.citation: J Cell Sci. 2006 Jan 15;119(Pt 2):199-207
references.pmid: 16410545
references.citation: Am J Hum Genet. 2001 Dec;69(6):1198-209
references.pmid: 11592034
references.citation: Cell. 1991 Sep 20;66(6):1121-31
references.pmid: 1913804
references.citation: Neuromuscul Disord. 1997 Mar;7(2):91-8
references.pmid: 9131649
references.citation: J Cell Biol. 2001 Jul 23;154(2):435-45
references.pmid: 11470830
references.citation: EMBO J. 1999 Feb 15;18(4):863-70
references.pmid: 10022829
references.citation: Trends Biochem Sci. 2001 Feb;26(2):118-24
references.pmid: 11166570
references.citation: Am J Hum Genet. 2009 Jul;85(1):76-86
references.pmid: 19576565
references.citation: J Invest Dermatol. 2004 Jun;122(6):1372-80
references.pmid: 15175026
references.citation: Nature. 1998 Jul 23;394(6691):388-92
references.pmid: 9690476
references.citation: Brain. 2013 Jan;136(Pt 1):269-81
references.pmid: 23288328
references.citation: Am J Hum Genet. 2013 Jul 11;93(1):29-41
references.pmid: 23768512
references.citation: Nat Genet. 2012 May;44(5):575-80
references.pmid: 22522420
references.citation: Neurology. 2010 Jan 12;74(2):157-64
references.pmid: 20065251
references.citation: Nat Neurosci. 2008 Aug;11(8):923-31
references.pmid: 18641643
references.citation: Ann Neurol. 2012 Oct;72(4):550-8
references.pmid: 23109149
references.citation: Am J Hum Genet. 2013 Mar 7;92(3):354-65
references.pmid: 23453667
references.citation: Am J Hum Genet. 2012 Sep 7;91(3):541-7
references.pmid: 22958903
references.citation: Curr Opin Genet Dev. 2011 Jun;21(3):278-85
references.pmid: 21397493
references.citation: J Cell Biol. 1995 Jul;130(1):79-91
references.pmid: 7790379
references.citation: J Histochem Cytochem. 1998 Apr;46(4):449-57
references.pmid: 9524190
references.citation: Neuromuscul Disord. 2007 Apr;17(4):276-84
references.pmid: 17303423
references.citation: Biochem Biophys Res Commun. 1993 Apr 15;192(1):69-74
references.pmid: 8476435
references.citation: Nat Med. 2007 Jul;13(7):843-50
references.pmid: 17558415
references.citation: Brain. 2007 Oct;130(Pt 10):2725-35
references.pmid: 17878207
references.citation: Hum Mol Genet. 2013 May 1;22(9):1746-54
references.pmid: 23359570
references.citation: Brain Pathol. 2009 Oct;19(4):596-611
references.pmid: 18691338
references.citation: Muscle Nerve. 2009 Nov;40(5):883-9
references.pmid: 19705481
references.citation: Hum Mol Genet. 2003 Nov 1;12(21):2853-61
references.pmid: 12966029
references.citation: Nat Genet. 2001 Jun;28(2):151-4
references.pmid: 11381262
references.citation: J Cell Biol. 1993 Aug;122(4):809-23
references.pmid: 8349731
references.citation: Nat Genet. 2012 May;44(5):581-5
references.pmid: 22522421
references.citation: Am J Hum Genet. 2002 Nov;71(5):1033-43
references.pmid: 12369018
references.citation: FEBS Lett. 2006 Jun 12;580(14):3381-5
references.pmid: 16709410
references.citation: Dev Cell. 2001 Nov;1(5):717-24
references.pmid: 11709191
references.citation: Neuromuscul Disord. 2012 Feb;22(2):139-48
references.pmid: 22075033